Intrinsic Value of S&P & Nasdaq Contact Us

Avantor, Inc. AVTR NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
48/100
1/7 Pass
SharesGrow Intrinsic Value
$16.22
+97.8%
Analyst Price Target
$9.79
+19.4%

Avantor, Inc. (AVTR) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Radnor, PA, United States. The current CEO is Justin Miller.

AVTR has IPO date of 2019-05-17, 13,500 full-time employees, listed on the NYSE, a market capitalization of $5.59B.

About Avantor, Inc.

Avantor, Inc. is a global supplier of essential products and services to the biopharma, healthcare, education, government, advanced technologies, and applied materials industries. The company operates across the Americas, Europe, Asia, the Middle East, and Africa, offering a comprehensive portfolio that includes specialty chemicals and reagents, laboratory consumables, filtration and analytical equipment, single-use assemblies, and process chromatography solutions. Additionally, Avantor provides specialized services such as onsite laboratory support, clinical trial services, equipment management, procurement solutions, and biopharmaceutical scale-up and development assistance. Founded in 1904 and headquartered in Radnor, Pennsylvania, Avantor has established itself as a trusted partner for critical operational needs across its customer base.

📍 Radnor Corporate Center, Radnor, PA 19087 📞 610 386 1700
Company Details
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUnited States
ExchangeNYSE
CurrencyUSD
IPO Date2019-05-17
CEOJustin Miller
Employees13,500
Trading Info
Current Price$8.20
Market Cap$5.59B
52-Week Range7.265-16.17
Beta1.00
ETFNo
ADRNo
CUSIP05352A100
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message